津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600488 津药药业

已收盘 04-26 15:00:00

{"stockData":{"symbol":"600488","market":"SH","secType":"STK","nameCN":"津药药业","latestPrice":3.91,"timestamp":1714114800000,"preClose":3.89,"halted":0,"volume":5777201,"delay":0,"floatShares":1092000000,"shares":1094000000,"eps":0.1817,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"04-26 15:00:00","open":3.89,"high":3.92,"low":3.86,"amount":22487200,"amplitude":0.0154,"askPrice":3.91,"askSize":331,"bidPrice":3.9,"bidSize":1178,"shortable":0,"etf":0,"ttmEps":0.1817,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":3.89,"symbolType":"stock","openAndCloseTimeList":[[1714095000000,1714102200000],[1714107600000,1714114800000]],"highLimit":4.28,"lowLimit":3.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1093932680,"pbRate":1.45,"roa":"--","roe":"3.95%","epsLYR":0.107,"committee":-0.172127,"marketValue":4277000000,"floatMarketCap":4269000000,"peRate":21.518987,"changeRate":0.0051,"turnoverRate":0.0053,"status":0},"requestUrl":"/m/hq/s/600488","defaultTab":"news","newsList":[{"id":"2429481570","title":"津药药业最新公告：获得吸入用复方异丙托溴铵溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429481570","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429481570?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:27","pubTimestamp":1713947222,"startTime":"0","endTime":"0","summary":"津药药业公告，子公司津药和平(天津)制药有限公司收到国家药品监督管理局核准签发的关于吸入用复方异丙托溴铵溶液的《药品注册证书》。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400032726.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429786485","title":"津药药业(600488.SH)子公司收到吸入用复方异丙托溴铵溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429786485","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429786485?lang=zh_cn&edition=full","pubTime":"2024-04-24 15:56","pubTimestamp":1713945365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，公司子公司津药和平(天津)制药有限公司收到国家药品监督管理局核准签发的关于吸入用复方异丙托溴铵溶液的《药品注册证书》。吸入用复方异丙托溴铵溶液为国家医保乙类药品，是由异丙托溴铵和硫酸沙丁胺醇组成的复方制剂,适用于需要多种支气管扩张剂联合应用的患者，用于治疗气道阻塞性疾病有关的可逆性支气管痉挛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108365.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429196464","title":"津药药业：\n截至2024年4月19日，公司股东数为43,606户","url":"https://stock-news.laohu8.com/highlight/detail?id=2429196464","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429196464?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:02","pubTimestamp":1713873722,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业04月23日在投资者关系平台上答复投资者关心的问题。谢谢津药药业董秘：投资者您好！截至2024年4月19日，公司股东数为43,606户，感谢您的关注。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300038728.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428713095","title":"辅助生殖概念盘中拉升，津药药业涨2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428713095","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428713095?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:46","pubTimestamp":1713491194,"startTime":"0","endTime":"0","summary":"04月19日，辅助生殖概念盘中拉升，截至09点46分，辅助生殖概念整体指数上涨0.51%，报383.450点。从个股上来看，该概念的成分股中，津药药业涨2.16%，物产中大、思创医惠、仙琚制药涨幅居前。从资金上来看，截止发稿，辅助生殖概念主力净流入为-6203.20万，其中江苏吴中受到资金热捧，主力净流入548.99万；拉长时间线来看，该板块近20日主力资金净流入-42.17亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190946347a53e999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190946347a53e999&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428630105","title":"津药药业吸入用乙酰半胱氨酸溶液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2428630105","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2428630105?lang=zh_cn&edition=full","pubTime":"2024-04-18 17:48","pubTimestamp":1713433736,"startTime":"0","endTime":"0","summary":"新京报讯（记者刘旭）4月18日，津药药业发布公告宣布，子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。吸入用乙酰半胱氨酸溶液为国家医保乙类药物，是一种黏痰溶解剂，主要用于治疗浓稠黏液分泌物过多的呼吸道疾病，包括急性支气管炎、慢性支气管炎及其病情恶化者、肺气肿、黏稠物阻塞症以及支气管扩张症。根据米内网全国放大版的医院数据（含城市公立医院、县级公立医院、城市社区医院、乡镇卫生院）显示，2021年、2022年吸入用乙酰半胱氨酸溶液国内销售额分别为20.89亿元、20.81亿元。校对 卢茜","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418175017878fc362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418175017878fc362&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428568865","title":"津药药业：目前公司出口美国的产品有甲泼尼龙片和注射用甲泼尼龙琥珀酸钠冻干粉针以及原料药产品等","url":"https://stock-news.laohu8.com/highlight/detail?id=2428568865","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428568865?lang=zh_cn&edition=full","pubTime":"2024-04-18 17:11","pubTimestamp":1713431481,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘您好，贵公司目前旗下的甲泼尼龙片已经连续两年在美国市场占有率排名第一吗？目前贵公司出口美国的药物有多少种？谢谢。津药药业（600488.SH）4月18日在投资者互动平台表示,2023年，公司旗下产品甲泼尼龙片在美国市场占有率保持领先。目前公司出口美国的产品有甲泼尼龙片和注射用甲泼尼龙琥珀酸钠冻干粉针以及原料药产品等。文章来源：每日经济新闻原标题：津药药业：目前公司出口美国的产品有甲泼尼龙片和注射用甲泼尼龙琥珀酸钠冻干粉针以及原料药产品等","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719278b354021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719278b354021&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428551427","title":"津药药业：子公司获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428551427","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2428551427?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:22","pubTimestamp":1713428531,"startTime":"0","endTime":"0","summary":"津药药业：子公司获得药品注册证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181622397a53aedb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181622397a53aedb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428514225","title":"津药药业：产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428514225","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428514225?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:05","pubTimestamp":1713427500,"startTime":"0","endTime":"0","summary":"津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比0.73%。截至发稿，津药药业市值为40亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428556263","title":"津药药业：子公司吸入用乙酰半胱氨酸溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428556263","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2428556263?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:59","pubTimestamp":1713427167,"startTime":"0","endTime":"0","summary":"津药药业晚间公告称，子公司吸入用乙酰半胱氨酸溶液获得药品注册证书。本品是一种粘痰溶解剂，主要用于治疗浓稠粘液分泌物过多的呼吸道疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181559277a53ad0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181559277a53ad0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427813246","title":"津药药业大跌5.01% 主力净流出286万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427813246","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427813246?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:50","pubTimestamp":1713250203,"startTime":"0","endTime":"0","summary":"04月16日，津药药业股价大幅下跌，截至14点50分，津药药业下跌5.01%，报3.60元/股，创近2月新低，成交4254万元，换手率1.06%。资金动向截止发稿，津药药业获得主力净流出286万元，其中超大单流出266万元，大单流出18万元。北向资金方面，津药药业04月15日获得北向资金减持74.18万股，截至04月15日，北向资金当前共持有津药药业1437.98万股，市值5176万元，持股占流通股比为1.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161450317a53119b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161450317a53119b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426209234","title":"津药药业(600488)4月10日股东户数4.38万户，较上期减少0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426209234","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426209234?lang=zh_cn&edition=full","pubTime":"2024-04-12 17:21","pubTimestamp":1712913675,"startTime":"0","endTime":"0","summary":"证券之星消息，近日津药药业披露，截至2024年4月10日公司股东户数为4.38万户，较3月20日减少35.0户，减幅为0.08%。在化学制药行业个股中，津药药业股东户数高于行业平均水平，截至4月10日，化学制药行业平均股东户数为3.4万户。从股价来看，2024年3月20日至2024年4月10日，津药药业区间跌幅为5.52%，在此期间股东户数减少35.0户，减幅为0.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121723128b163182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121723128b163182&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425660407","title":"辅助生殖概念盘中跳水，奥锐特跌1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425660407","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425660407?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:55","pubTimestamp":1712541313,"startTime":"0","endTime":"0","summary":"04月08日，辅助生殖概念盘中跳水，截至09点55分，辅助生殖概念整体指数下跌3.01%，报419.790点。从个股上来看，该概念的成分股中，奥锐特跌1.00%，重药控股、津药药业、西陇科学跌幅居前。从资金上来看，截止发稿，辅助生殖概念主力净流入为-1.82亿，其中津药药业受到资金热捧，主力净流入495.87万；拉长时间线来看，该板块近20日主力资金净流入-35.68亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408095513861e3bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408095513861e3bda&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423343072","title":"津药药业(600488)3月20日股东户数4.39万户，较上期增加0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423343072","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2423343072?lang=zh_cn&edition=full","pubTime":"2024-03-29 17:18","pubTimestamp":1711703927,"startTime":"0","endTime":"0","summary":"证券之星消息，近日津药药业披露，截至2024年3月20日公司股东户数为4.39万户，较3月8日增加171.0户，增幅为0.39%。在化学制药行业个股中，津药药业股东户数高于行业平均水平，截至3月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2024年3月8日至2024年3月20日，津药药业区间涨幅为7.2%，在此期间股东户数增加171.0户，增幅为0.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032917200587c4bb4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032917200587c4bb4c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423110333","title":"津药药业：本期计提各项减值准备合计6597.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423110333","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2423110333?lang=zh_cn&edition=full","pubTime":"2024-03-29 00:25","pubTimestamp":1711643100,"startTime":"0","endTime":"0","summary":"津药药业（SH 600488，收盘价：3.96元）3月29日发布公告称，公司本期对各项资产进行减值测试，计提各项减值准备合计6597.35万元，收回或转回减值准备877.49万元，上述因素将减少公司2023年损益5719.86万元。2023年1至6月份，津药药业的营业收入构成为：甾体激素类占比53.69%，制剂占比35.47%，氨基酸类原料药占比9.78%，其他业务占比0.97%。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032900290787c168ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032900290787c168ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422116188","title":"津药药业2023年净利1.17亿同比增长230.6% 总经理李书箱薪酬15.06万","url":"https://stock-news.laohu8.com/highlight/detail?id=2422116188","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2422116188?lang=zh_cn&edition=full","pubTime":"2024-03-28 23:09","pubTimestamp":1711638558,"startTime":"0","endTime":"0","summary":"挖贝网3月28日，津药药业 近日发布2023年年度报告，报告期内公司实现营业收入3,782,826,621.15元，同比增长2.55%；归属于上市公司股东的净利润117,052,520.50元，同比增长230.60%。报告期内经营活动产生的现金流量净额为783,008,315.33元，归属于上市公司股东的净资产2,953,554,191.30元。公告显示，报告期内董事、监事、高级管理人员报酬合计757.61万元。截至2023年12月31日，公司总股本1,093,932,680股，以此计算合计分配现金红利95,172,143.16元（含税），本年度公司现金分红比例为81.31%，剩余824,691,991.79元结转以后年度分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032823115887c1319a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032823115887c1319a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422167023","title":"津药药业：2023年度净利润同比增长230.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422167023","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2422167023?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:45","pubTimestamp":1711622718,"startTime":"0","endTime":"0","summary":"格隆汇3月28日丨津药药业(600488.SH)公布2023年度报告，报告期实现营业收入37.83亿元，同比增长2.55%；归属于上市公司股东的净利润1.17亿元，同比增长230.60%；基本每股收益0.107元。公司董事会拟定的本次利润分配预案为：拟以公司2023年度利润分配股权登记日的总股本为基数，向全体股东每10股派发现金红利0.87元（含税）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281845248b6d72ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281845248b6d72ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422538919","title":"辅助生殖概念盘中跳水，津药药业跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422538919","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422538919?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:38","pubTimestamp":1711330684,"startTime":"0","endTime":"0","summary":"03月25日，辅助生殖概念盘中跳水，截至09点37分，辅助生殖概念整体指数下跌0.60%，报441.030点。从个股上来看，该概念的成分股中，津药药业跌0.24%，爱威科技、科美诊断跌幅居前。从资金上来看，截止发稿，辅助生殖概念主力净流入为-2452.09万，其中贝瑞基因受到资金热捧，主力净流入1940.46万；拉长时间线来看，该板块近20日主力资金净流入-38.48亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325093804791c7e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325093804791c7e51&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418865503","title":"津药药业03月11日主力资金流出28万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2418865503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418865503?lang=zh_cn&edition=full","pubTime":"2024-03-11 15:17","pubTimestamp":1710141464,"startTime":"0","endTime":"0","summary":"03月11日, 津药药业股价涨1.54%，报收3.95元，成交金额1721万元，换手率0.40%，振幅2.06%，量比0.69。津药药业今日主力资金净流出28万元，连续3日净流出，上一交易日主力净流出163万元，今日环比减少82.82%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为63.64%，平均跌幅为2.13%。该股近5个交易日下跌2.23%，主力资金累计净流出502万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入521万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111522288770e891&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111522288770e891&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417730000","title":"津药药业：3月7日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2417730000","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2417730000?lang=zh_cn&edition=full","pubTime":"2024-03-07 18:01","pubTimestamp":1709805660,"startTime":"0","endTime":"0","summary":"津药药业（SH 600488，收盘价：3.87元）3月7日晚间发布公告称，公司第九届第五次董事会会议于2024年3月7日以通讯方式召开。审议了《关于公司组织机构调整的议案》等。2023年1至6月份，津药药业的营业收入构成为：甾体激素类占比53.69%，制剂占比35.47%，氨基酸类原料药占比9.78%，其他业务占比0.97%。津药药业的董事长是徐华，男，57岁，学历背景为硕士；总经理是李书箱，男，51岁，学历背景为硕士。截至发稿，津药药业市值为42亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307180319875f0f5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307180319875f0f5b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417463881","title":"津药药业：截至目前，公司暂未涉及氘代技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2417463881","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2417463881?lang=zh_cn&edition=full","pubTime":"2024-03-05 16:12","pubTimestamp":1709626344,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问贵公司有没有氘代技术储备？有没有氘代药的开发计划？谢谢津药药业（600488.SH）3月5日在投资者互动平台表示，截至目前，公司暂未涉及氘代技术。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403051616598b070e53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403051616598b070e53&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2001-06-18","address":"天津市东丽区开发区西区新业九街19号","stockEarnings":[{"period":"1week","weight":0.0514},{"period":"1month","weight":-0.0347},{"period":"3month","weight":-0.1199},{"period":"6month","weight":-0.2373},{"period":"1year","weight":-0.1398},{"period":"ytd","weight":-0.2061}],"companyName":"津药药业股份有限公司","boardCode":"AI0027","perCapita":"25039股","boardName":"医药制造业","registeredCapital":"109393万元","compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0071},{"period":"3month","weight":0.049},{"period":"6month","weight":0.0116},{"period":"1year","weight":-0.0647},{"period":"ytd","weight":0.0262}],"survey":"　　津药药业股份有限公司主要从事皮质激素类、氨基酸类原料药及制剂的研发、生产和销售，公司主要产品地塞米松系列、泼尼松系列、甲泼尼龙系列、倍他米松系列、氨基酸原料药、片剂、小容量注射剂、软膏剂、乳膏剂、涂膜剂、凝胶剂、膜剂、栓剂、硬胶囊剂、丸剂、冻干粉针剂。公司多次获得中国化学制药协会 “国内原料药出口十强企业”称号。","serverTime":1714118514998,"listedPrice":11.25,"stockholders":"43606人(较上一季度减少0.55%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"津药药业,600488,津药药业股票,津药药业股票老虎,津药药业股票老虎国际,津药药业行情,津药药业股票行情,津药药业股价,津药药业股市,津药药业股票价格,津药药业股票交易,津药药业股票购买,津药药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}